Clinical Trials Browser

Phase 2/3 × Anxiety Disorders × Methylphenidate × Clear all

NCT05474846 2025-11-06

Combination Therapy for Treatment of Sleep Disturbance in Patients With Advanced Cancer

Phase 2/3 Recruiting

Anxiety Disorders, Depression, Fatigue, Neoplasms